Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Carcinoma, Renal Cell 7Melanoma 5Head and Neck Neoplasms 5Triple Negative Breast Neoplasms 4Urinary Bladder Neoplasms 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Carcinoma, Transitional Cell 3Neoplasms 2Lung Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Urinary Bladder Diseases 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Mesothelioma, Malignant 1Kidney Neoplasms 1Gastrointestinal Neoplasms 1Carcinoma, Merkel Cell 1Bites and Stings 1

Interventions

Mitomycin 3vofatamab 2pembrolizumab 2Nivolumab 2Gemcitabine 2Cystectomy 2Cisplatin 2B701 protein, Human herpesvirus 6 2valrubicin 1tislelizumab 1relatlimab 1enzalutamide 1enfortumab vedotin 1durvalumab 1Water 1Urinary Diversion 1Standard of Care 1Radiosurgery 1Radiation Dose Hypofractionation 1Multiparametric Magnetic Resonance Imaging 1Microscopy 1Immunonutrition Diet 1Immune Checkpoint Inhibitors 1Gels 1Fluorouracil 1Docetaxel 1Cystoscopy 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Diseases × Immune Checkpoint Inhibitors × Genitourinary × Clear all
NCT05241340 2025-10-24

RAD-VACCINE

The Methodist Hospital Research Institute

Phase 2 Active not recruiting
33 enrolled
Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡